FHIR © HL7.org  |  Server Home  |  XIG Home  |  XIG Stats  |  Server Source  |  FHIR  

FHIR IG Statistics: FHIR Resources

Resources - Immunization, Realm US

19,481 resources

Type: Text:

By Version

By Authority

 

Start Prev Rows 12800 - 13000 Next

PackageVersionIdentityName/TitleStatusFMMWGDateAuth
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.600.261Diagnosis of Hypertensionactive2021-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.600.263Diagnosis of Hypertensionactive2024-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.600.467Follow Up for Adolescent Depressionactive2024-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.600.468Follow Up for Adult Depressionactive2024-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.600.469Adolescent Depression Medicationsactive2023-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.600.470Adult Depression Medicationsactive2024-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.600.537Referral for Adolescent Depressionactive2023-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.600.538Referral for Adult Depressionactive2023-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.600.791Patient Declinedactive2025-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.600.805Weight Reduction Recommendedactive2022-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.600.810Recommendation to Increase Physical Activityactive2017-05hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.600.823Referral or Counseling for Alcohol Consumptionactive2022-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.6366.117Absence of Cervixactive2024-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.666.5.1743General or Neuraxial Anesthesiaactive2022-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.666.5.1940Immunocompromised Conditionsactive2022-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.666.5.2262CABG Surgeriesactive2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.666.5.2328Immunocompromised Conditions I10active2022-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.666.5.2343Immunocompromised Conditionsactive2024-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.666.5.3011Acute Myocardial Infarctionactive2022-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.666.5.3024Acute Myocardial Infarctionactive2016-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.666.5.307Encounter Inpatientactive2020-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.666.5.335Bone Marrow Transplantactive2021-09hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.666.5.336Bone Marrow Transplantactive2024-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.666.5.404Bone Marrow Transplantactive2024-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.666.5.623Acute Myocardial Infarctionactive2024-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.666.5.694CABG Surgeriesactive2024-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.666.5.737PCIactive2018-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.666.5.747Endotracheal Intubationactive2017-05hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.67.1.101.1.128Bipolar Disorderactive2024-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.67.1.101.1.246Personality Disorder Emotionally Labileactive2024-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.67.1.101.1.247Personality Disorder Emotionally Labileactive2022-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.67.1.101.1.248Personality Disorder Emotionally Labileactive2022-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.67.1.101.1.249Personality Disorder Emotionally Labileactive2023-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.67.1.101.1.254Dysthymiaactive2022-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.67.1.101.1.256Dysthymiaactive2022-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.67.1.101.1.257Dysthymiaactive2023-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.67.1.101.1.262Deceasedactive2014-05hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.67.1.101.1.263PHQ 9 and PHQ 9M Toolsactive2022-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.67.1.101.1.269Hepatitis Bactive2017-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.67.1.101.1.271Hepatitis Bactive2017-05hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.67.1.101.1.272Hepatitis Bactive2023-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.67.1.101.1.43Bipolar Disorderactive2022-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.67.1.101.1.44Bipolar Disorderactive2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.67.1.101.1.45Bipolar Disorderactive2022-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.67.1.101.11.721Deceasedactive2022-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.67.1.101.11.723PHQ-9 Toolactive2022-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.6929.2.1000Estimated Glomerular Filtration Rateactive2024-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.6929.2.1002Urine Albumin Creatinine Ratioactive2025-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.6929.3.1000Estimated Glomerular Filtration Rateactive2022-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.6929.3.1007Urine Albumin Creatinine Ratioactive2022-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.8420.2.1000Strabismic Amblyopiaactive2019-09hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.8420.2.1001Strabismic Amblyopiaactive2019-09hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.8420.2.1002Refractive Amblyopiaactive2019-09hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.8420.2.1003Refractive Amblyopiaactive2019-09hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.8420.2.1004Routine Ophthalmological Examinationactive2019-09hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.8420.2.1005Pediatric Best Corrected Visual Acuity Examactive2019-09hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.8420.2.1006LogMAR Visual Acuity Examactive2019-09hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.8420.2.1007Aphakiaactive2019-09hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.8420.2.1008Aphakiaactive2019-09hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.8420.2.1009Infantile and Juvenile Cataractactive2019-09hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.8420.2.1010Infantile and Juvenile Cataractactive2019-09hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.8420.2.1011Congenital Corneal or Anterior Segment Conditionsactive2019-09hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.8420.2.1012Congenital Corneal or Anterior Segment Conditionsactive2019-09hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.8420.2.1013Eyelid or Orbital Conditionsactive2019-09hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.8420.2.1014Eyelid or Orbital Conditionsactive2019-09hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.8420.2.1015Coloboma of Optic Discactive2019-09hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.8420.2.1016Coloboma of Optic Discactive2019-09hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.8420.2.1017Hemorrhage of Optic Nerve Sheathactive2019-09hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.8420.2.1018Hemorrhage of Optic Nerve Sheathactive2019-09hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.8420.2.1019Optic Nerve Hypoplasiaactive2019-09hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.8420.2.1020Optic Nerve Hypoplasiaactive2019-09hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.8420.2.1021Disorder of Visual Cortex Due to Underlying Conditionactive2019-09hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.8420.2.1022Disorder of Visual Cortex Due to Underlying Conditionactive2019-09hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.8420.2.1023Cortical Blindnessactive2019-09hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.8420.2.1024Cortical Blindnessactive2019-09hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.8420.2.1025Congenital Condition of Retinaactive2019-09hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.8420.2.1026Congenital Condition of Retinaactive2019-09hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.8420.3.1000Strabismic Amblyopiaactive2019-09hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.8420.3.1001Refractive Amblyopiaactive2019-09hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.8420.3.1002Routine Ophthalmological Examinationactive2019-09hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.8420.3.1003Pediatric Best Corrected Visual Acuity Examactive2022-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.8420.3.1004LogMAR Visual Acuity Examactive2022-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.8420.3.1005Aphakiaactive2019-09hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.8420.3.1006Infantile and Juvenile Cataractactive2019-09hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.8420.3.1007Congenital Corneal or Anterior Segment Conditionsactive2019-09hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.8420.3.1008Eyelid or Orbital Conditionsactive2019-09hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.8420.3.1009Coloboma of Optic Discactive2019-09hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.8420.3.1010Hemorrhage of Optic Nerve Sheathactive2019-09hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.8420.3.1011Optic Nerve Hypoplasiaactive2019-09hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.8420.3.1012Disorder of Visual Cortex Due to Underlying Conditionactive2019-09hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.8420.3.1013Cortical Blindnessactive2019-09hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.8420.3.1014Congenital Condition of Retinaactive2019-09hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.88.12.3221.6.2Allergy and Intolerance Typeactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.88.12.3221.7.2Problem Type (SNOMEDCT)active2025-05hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.88.12.3221.8.7SPL Drug Route of Administration Terminologyactive2024-07hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.88.12.80.62Vital Sign Result Typeactive2024-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.114222.4.11.3180NHSNInsertionSiteCodeactive2020-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.114222.4.11.3181NHSNRoleOfPerformerCodeactive2022-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.114222.4.11.3182NHSNReasonForInsertionCodeactive2020-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.114222.4.11.3183NHSNSkinPreparationCodeactive2020-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.114222.4.11.3184NHSNSterileBarrierCodeactive2020-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.114222.4.11.3185NHSNCatheterTypeCodeactive2020-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.114222.4.11.3194NHSNSignificantPathogenCodeactive2022-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.114222.4.11.3195NHSNCriterionOfDiagnosisCodeactive2022-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.114222.4.11.3196NHSNInfectionConditionCodeactive2022-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.114222.4.11.3234NHSNPopulationCategoryCodeactive2020-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.114222.4.11.3247NHSNTimingCodeactive2020-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.114222.4.11.3248NHSNEligibilityCodeactive2020-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.114222.4.11.3249NHSNSpecimenTypeCodeactive2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.114222.4.11.3283NHSNOrganismASTCodeactive2020-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.114222.4.11.3360NHSNAntimicrobialAgentAURPCodeactive2025-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.114222.4.11.3361NHSNRouteOfAdministrationAURPCodeactive2020-07hl7
us.nlm.vsacR4ValueSet/2.16.840.1.114222.4.11.3595NHSNPopulationSummaryReportTypeCodeactive2022-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.114222.4.11.6007NHSNVascularAccessTypeCodeactive2022-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.114222.4.11.6008NHSNSuspectedSourceTypeCodeactive2020-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.114222.4.11.6042NHSNVascularAccessSiteCodeactive2020-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.114222.4.11.6051NHSNClosureTechniqueCodeactive2020-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.114222.4.11.6074NHSNStaphAureusTestResultsactive2020-07hl7
us.nlm.vsacR4ValueSet/2.16.840.1.114222.4.11.7160NHSNStaphAureusSpecificTestactive2020-07hl7
us.nlm.vsacR4ValueSet/2.16.840.1.114222.4.11.7214NHSNSameDayOutcomeMeasureactive2022-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.114222.4.11.7215NHSNInfectionFirstReportedSourceactive2022-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.114222.4.11.7232NHSNRaceCategoryactive2020-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.114222.4.11.7233NHSNPreviousPatientLocationactive2020-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.114222.4.11.7237NHSNBloodCollectionLocationactive2020-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.114222.4.11.7238NHSNPreviousFacilityactive2020-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.114222.4.11.7239NHSNContraindicationTypeactive2020-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.114222.4.11.7240NHSNCarbaTestMethodactive2020-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.114222.4.11.7241NHSNCarbaDetectTypeactive2020-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.114222.4.11.7242NHSNCdiffTestMethodactive2020-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.114222.4.11.7338NHSNStartOrContinuationactive2020-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.114222.4.11.7353NHSNSummaryBloodProductUsageactive2020-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.114222.4.11.836Raceactive2012-10hl7
us.nlm.vsacR4ValueSet/2.16.840.1.114222.4.11.837Ethnicityactive2012-10hl7
us.nlm.vsacR4ValueSet/2.16.840.1.114222.4.11.877Detailed Ethnicityactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.113883.3.67.1.101.3.2444Major Depression Including Remissionactive2021-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1222.140Ferritinactive2024-07hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.113.12.1005Rheumatoid Arthritisactive2024-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.113.11.1080Rheumatoid Arthritisactive2021-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.113.11.1081Rheumatoid Arthritisactive2022-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1222.1428Myalgiaactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1222.1439Vomitingactive2024-07hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1222.1525Cognitive disorder Diagnosis ICD10active2024-06hl7
hl7.fhir.us.ccdaR4ValueSet/2.16.840.1.113883.11.20.4.1DischargeSummaryDocumentTypeCodetrial-usecgp2025-07hl7
hl7.fhir.us.ccdaR4ValueSet/2.16.840.1.113883.1.11.20.22HPDocumentTypetrial-usecgp2025-07hl7
hl7.fhir.us.ccdaR4ValueSet/2.16.840.1.113762.1.4.1099.10Care Plan Document Typetrial-usecgp2025-07hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1196.1139S4G Hyperlipidemiaactive2022-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1196.1291S4G Cardiomyopathyactive2022-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1196.1292S4G Tricuspid valve disorderactive2022-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1196.1293S4G Pompe diseaseactive2022-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1196.1294S4G Malignant hyperthermiaactive2022-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1196.1295S4G Malignancyactive2022-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1196.1297S4G Intestinal polypactive2022-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1196.1298S4G Hamartomaactive2022-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1196.1299S4G Diabetes mellitusactive2022-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1196.1300S4G Muscular dystrophy and weaknessactive2022-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1196.1325S4G Hamartoma and S4G Intestinal Polypactive2022-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1196.1326S4G Malignancy and S4G Intestinal Polypactive2022-08hl7
hl7.fhir.us.registry-protocolsR4ValueSet/SmokingStatusSmoking Statusactivecic2023-11hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.526.2.168Cardiac Surgeryactive2025-02hl7
fhir.virtually.healthcareR4ValueSet/document-entry-typeDocumentEntry Typedraft2025-08hl7
fhir.virtually.healthcareR4ValueSet/specialtySpecialtydraft2025-08hl7
fhir.virtually.healthcareR4ValueSet/document-entry-classDocumentEntry Classdraft2025-08hl7
fhir.virtually.healthcareR4ValueSet/document-entry-mimetypeDocumentEntry mimeTypedraft2025-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.666.5.1668CABG Surgeriesactive2022-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1099.10Care Plan Document Typeactive2024-10hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1021.30AdministrationUnitDoseFormactive2024-06hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7185Industry CDC Census 2002active2013-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7184Occupation CDC Census 2002active2013-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.8028Occupation CDC SOC 2010active2021-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7187Industry CDC Census 2010active2013-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7186Occupation CDC Census 2010active2013-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.8027Industry CDC Census 2012active2021-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.8025Industry CDC NAICS 2012active2021-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.8026Occupation CDC Census 2012active2021-01
us.nlm.vsacR4ValueSet/1.3.6.1.4.1.12009.10.2.5LOINC Imaging Document Codesactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.11.20.8.1ProgressNoteDocumentTypeCodeactive2024-07hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1186.5Common refutations for substance causes for allergy and intolerance documentationactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.11.20.1.1SurgicalOperationNoteDocumentTypeCodeactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.1.11.20.2.3ReferralDocumentTypeactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.93Albuminuria I10active2023-09hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.189SGLT2iactive2023-10hl7
us.nlm.vsacR4ValueSet/2.16.840.1.114222.4.11.3591Payer Typeactive2025-04hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7162Country (GEC)active2018-12
ca.on.dhdr.r4.v4R4ValueSet/drug-identification-number-DINDrug Identification Number-DINactive2022-03hl7
fhir.cdc.opioid-cds-r4R4ValueSet/pain-treatment-planPain treatment planactive2023-05hl7
signal.core.r4R4ValueSet/questionnaire-ccars-school-developmentQuestionnaire CCARS School Developmentdraft1pahl7
signal.core.r4R4ValueSet/questionnaire-ccars-school-problemsQuestionnaire CCARS School Problemsdraft1pahl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.113883.1.11.19563Personal Relationship Role Type Value Setactive2013-12
us.nlm.vsacR4ValueSet/2.16.840.1.113883.1.11.19563Personal Relationship Role Typeactive2024-06hl7
fhir.r4.wales.testR4ValueSet/DataStandardsWales-OccupationData Standards Wales Occupationdraft2023-05hl7
fhir.r4.wales.testR4ValueSet/DataStandardsWales-ReligionData Standards Wales Religionactive2023-08hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.113883.11.20.9.21AgePQ_UCUMactive2016-01
fhir.r4.nhsengland.programmeR4ValueSet/England-FlagCodeProgrammeEngland Flag Code Programmedraft2024-02hl7
fhir.r4.nhsengland.programmeR4ValueSet/England-FlagCodeRAEngland Flag Code RAdraft2024-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.11.20.9.22ProcedureAct statusCodeactive2024-06hl7
fhir.r4.ukcore.stu3.currentbuildR4ValueSet/UKCore-OverseasVisitorChargingCategoryUK Core Overseas Visitor Charging Categoryretired2021-09hl7
fhir.r4.ukcore.stu3.currentbuildR4ValueSet/UKCore-SDSJobRoleNameUK Core SDS Job Role Nameretired2021-09hl7
fhir.r4.ukcore.stu3.currentbuildR4ValueSet/UKCore-LanguageAbilityModeUK Core Language Ability Moderetired2021-09hl7
fhir.r4.ukcore.stu3.currentbuildR4ValueSet/UKCore-TreatmentCategoryUK Core Treatment Categoryretired2021-09hl7
fhir.r4.nhsengland.programmeR4ValueSet/England-FlagConditionCodeEngland Flag Condition Codedraft2024-02hl7